Tom Oxley to Keynote Seventh Annual Bioelectronic Medicine Forum in NYC

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Tom Oxley, the CEO of Synchron Inc., will keynote the Seventh Annual Bioelectronic Medicine Forum. Synchron's internationally acclaimed stentrode device can record brain activity from within a blood vessel. In the intended application of the technology, the user’s thoughts are captured, decoded and passed wirelessly through the skin to enable control of digital devices that enable movement and speech restoration to previously paralyzed patients.The event will take place on April 5, 2024 at the New York Academy of Medicine in Manhattan.

Executives and entrepreneurs from several early stage and startup bioelectronic medicine firms will make presentations at the conference. Among these are Sinaptica Therapeutics, Neurosoft Bioelectronics, Helius Medical, PathMaker Neurosystems, Five Liters, Nia Therapeutics, Backstop Neural, and NeuroSigma.

There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, JoJo Platt, and Victor Pikov will moderate sessions at the event. A panel on investment will feature Diana Saraceni, General Partner at Panakes Partners, David Neustaedter, Venture Partner at Deerfield, and others.

Cirtec Medical is the Platinum Sponsor of the conference. CorTec is the Bronze Sponsor.